Chimin Health Management Co., Ltd. (SHA:603222)
China
· Delayed Price · Currency is CNY 9.11
+0.22 (2.47%)
At close: Mar 9, 2026
Chimin Health Management Revenue
Chimin Health Management had revenue of 178.27M CNY in the quarter ending September 30, 2025, a decrease of -17.86%. This brings the company's revenue in the last twelve months to 637.78M, down -29.10% year-over-year. In the year 2024, Chimin Health Management had annual revenue of 775.73M, down -13.28%.
Revenue (ttm)
637.78M
Revenue Growth
-29.10%
P/S Ratio
7.47
Revenue / Employee
319.85K
Employees
1,994
Market Cap
4.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 775.73M | -118.78M | -13.28% |
| Dec 31, 2023 | 894.51M | 57.27M | 6.84% |
| Dec 31, 2022 | 837.24M | -261.23M | -23.78% |
| Dec 31, 2021 | 1.10B | 220.83M | 25.16% |
| Dec 31, 2020 | 877.64M | 106.36M | 13.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao NovelBeam Technology | 602.61M |
| SWS Hemodialysis Care | 806.82M |
| Well Lead Medical | 1.64B |
| Jiangsu Apon Medical Technology | 380.70M |
| Jiangxi Sanxin Medtec | 1.59B |
| Hangzhou Alltest Biotech | 911.30M |
| Caina Technology | 341.55M |
| Zhonghong Pulin Medical Products | 2.48B |